| Dr Elaine K Brown, MD | |
|
2900 12th Ave N Ste 240, Billings, MT 59101-7506 | |
| (406) 237-5877 | |
| (406) 237-5880 |
| Full Name | Dr Elaine K Brown |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 2900 12th Ave N Ste 240, Billings, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427095645 | NPI | - | NPPES |
| 112173100 | Medicaid | WY | |
| H6078 | Other | TX | STATE LICENSE NUMBER |
| 8138 | Other | MT | MONTANA STATE LICENSE |
| A63645 | Other | CO | STATE LICENSE NUMBER |
| 0154193 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 8138 (Montana) | Primary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20190828001034 |
News Archive
Chronic childhood illnesses – asthma, allergies, autism, cancer, obesity and diabetes – are plaguing our nation, and credible scientific evidence links chemical exposure to many of these conditions.
OPKO Health, Inc. has entered into a definitive agreement to acquire Inspiro Medical Ltd., an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro's Inspiromatic is a "smart" easy-to-use dry powder inhaler with several advantages over existing devices.
Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).
In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston concluded in a New England Journal of Medicine review article.
For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elaine K Brown, MD 1138 Moon Valley Rd, Billings, MT 59105-2024 Ph: (406) 256-3944 | Dr Elaine K Brown, MD 2900 12th Ave N Ste 240, Billings, MT 59101-7506 Ph: (406) 237-5877 |
News Archive
Chronic childhood illnesses – asthma, allergies, autism, cancer, obesity and diabetes – are plaguing our nation, and credible scientific evidence links chemical exposure to many of these conditions.
OPKO Health, Inc. has entered into a definitive agreement to acquire Inspiro Medical Ltd., an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro's Inspiromatic is a "smart" easy-to-use dry powder inhaler with several advantages over existing devices.
Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).
In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston concluded in a New England Journal of Medicine review article.
For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.
› Verified 2 days ago
Elizabeth V Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-5000 | |
Daniel M Molloy, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, Ste 245w, Billings, MT 59101 Phone: 406-238-6010 Fax: 406-238-6022 | |
James F Metherell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dana P. Damron, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Dana C. Edwards, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Alexis N Hokenstad, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Christa Lynn Boggis-delacruz, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1045 N 30th St, Billings, MT 59101 Phone: 406-238-2500 |